Magic Slim capsules, supplied in 60 count bottles, distributed by MyNicKnaxs, LLC, Deltona, FL
Published June 18, 2014 · Recall initiated: January 24, 2014
Summary
FDA records drug Class I recall D-1379-2014, published June 18, 2014 and initiated January 24, 2014. Recalling firm: MyNicNaxs, Inc.; Status: Terminated; Reported quantity: unknown; Lot: ALL LOTS. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MyNicNaxs, Inc.
- Distributor
- Nationwide
- Lot
- ALL LOTS
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMeizitang Strong Version Botanical Slimming, Soft Gel Capsules, 650 mg, supplied in 30 count bottles,June 18, 2014
- FDAMeizi Evolution Soft Gel Capsules, supplied in 30 count bottles, distributed by MyNicKnaxs, LLC, Deltona, FLJune 18, 2014
- FDAPill for weight reduction, (Japanese Chinese Formula from Japan Hokkaido Cangye Pharmacy Co, Ltd) 400 mg,June 18, 2014
- FDAFruta BIO 400 mg capsules, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FLJune 18, 2014
- FDASlim Xtreme Weight loss capsules, 500 mg, supplied in 30 count bottles, Another product from Globe AllJune 18, 2014
- FDADr. Reddy's Metoprolol Succinate Extended Release Tablets, USP 25 mg. 100-count bottle, Rx only, ManufacturedJune 18, 2014
Questions about this recall
Was Magic Slim capsules, supplied in 60 count bottles, distributed by MyNicKnaxs, LLC, Deltona, FL recalled?
Yes. FDA published recall D-1379-2014 on June 18, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail